Allergy Shots vs. Allergy Drops/Tablets: SCIT vs. SLIT Explained

Allergy Shots, Drops, and Tablets: The Main Difference

Allergy shots can treat a broader selection of relevant allergens. FDA-approved allergy tablets offer treatment at home for specific grass, ragweed, or dust mite allergies. Liquid allergy drops are a separate, off-label U.S. option whose evidence depends on the formulation and dose. They should not be treated as interchangeable products.

Allergen immunotherapy repeatedly exposes your immune system to selected allergens to reduce its sensitivity over time. It can reduce symptoms and medication needs, and benefits sometimes continue after treatment stops. It is not a guaranteed permanent cure or immediate relief for a bad allergy day. AAAAI: lasting benefits of immunotherapy

This guide compares SCIT, or subcutaneous immunotherapy, with SLIT, or sublingual immunotherapy, for environmental allergies affecting the nose and eyes. Food allergy treatment and insect venom immunotherapy require separate assessment and protocols.

SCIT vs. SLIT: Head-to-Head Comparison

Sources: AAO-HNSF: treatment comparison, FDA: injectable extracts, and AAAAI: immunotherapy methods. Product-specific instructions and precautions are detailed below.

Editorial research date: October 26, 2026. Approval, age, and labeling statements below refer to the United States. Insurance coverage must be checked against your own plan.

Who Is a Candidate for Allergen Immunotherapy?

Immunotherapy is worth discussing when a confirmed environmental allergy causes troublesome symptoms despite appropriate medicine and exposure reduction, or when you prefer a treatment that may reduce your longer-term medication needs. The starting point is a symptom history supported by relevant skin or specific IgE blood testing.

A positive test alone is not a reason to treat an allergen. Your allergist should connect the result with exposures and symptoms. For example, a positive grass test matters more if grass season reliably disrupts your sleep or outdoor activities than if you have no symptoms during that season. AAO-HNSF: immunotherapy patient questions

Bring your results and medication list to the discussion. Our Allergy Testing Guide explains how sensitization differs from a clinically important allergy.

SCIT: How Allergy Shots Work

Buildup and maintenance

With conventional SCIT, the clinician gradually increases the injected allergen dose before moving to a maintenance schedule. A common pattern is:

• Buildup: injections once or twice a week for approximately 3–6 months.
• Maintenance: injections generally every 2–4 weeks, individualized to the prescription and your response.
• Longer-term treatment: maintenance commonly continues for 3–5 years, with the stopping decision made together with your allergist.

Accelerated schedules are available in some practices, but they require different planning and monitoring. Missed visits, reactions, or changes in health may alter the schedule. AAAAI: allergy shot schedules

The practical commitment starts before monthly visits. Ask how often you must attend during buildup and whether those appointments fit your work, school, travel, and caregiving responsibilities.

Several allergens can be treated—but mixing has limits

An allergist may prescribe shots for more than one important trigger, such as relevant tree pollen, ragweed, and dust mites. This flexibility can matter when several unrelated exposures contribute substantially to symptoms.

That does not mean every positive test belongs in one vial. Extract compatibility and the dose of each component matter. Some combinations lose potency when mixed, so separate treatment vials—and more than one injection per visit—may be needed. AAAAI/ACAAI: extract mixing guidance

FDA licensing of an injectable extract does not mean that every possible patient-specific mixture has separately undergone an FDA efficacy trial. Ask which allergens are included, why they matter, and how the prescription delivers an appropriate dose. AAAAI: patient-specific extract preparation

The observation period is part of treatment

Shots are normally given in a setting with trained staff and equipment to manage anaphylaxis. Plan to stay at least 30 minutes after injections, or longer if instructed. Serious reactions can occur after leaving, so ask what symptoms to watch for and whether you should carry epinephrine. AAAAI: allergy shot precautions

For appointment details, see our Allergy Shots Guide.

SLIT: FDA-Approved Allergy Tablets vs. Liquid Drops

SLIT delivers allergen to immune tissue under the tongue. The tablet or liquid is used according to its prescribed instructions. Being needle-free does not remove the possibility of a serious allergic reaction.

Which allergy tablets are FDA-approved?

All four products below are approved for allergic rhinitis, with or without conjunctivitis, caused by the specified allergen and confirmed with appropriate testing. Their approved age range is currently 5 through 65 years.

Sources: FDA prescribing information for Grastek, Oralair, Ragwitek, and Odactra.

Tablets are allergen-specific, but “single allergen” is an oversimplification: Oralair contains five related grasses, and Odactra contains two mite species. None is an all-purpose tablet for trees, pets, molds, and weeds together. There is currently no FDA-approved tablet for cat, dog, mold, or mountain cedar allergy. FDA: approved sublingual tablets

What taking a tablet involves

The first dose is administered under medical supervision with at least 30 minutes of observation. If tolerated, subsequent doses are usually taken at home. You need prescribed epinephrine, training in its use, and clear instructions for reactions and treatment interruptions.

Follow the product's directions for placing the tablet under the tongue, allowing it to dissolve, and delaying swallowing. Labels also instruct patients to avoid food or drink for 5 minutes afterward. Children require adult supervision. This is a daily medication routine, not something to take only when symptoms appear. FDA: Grastek Medication Guide · FDA: Oralair instructions

What is different about liquid allergy drops?

Some U.S. clinicians prescribe liquid extracts under the tongue, including custom mixtures. These commonly use extracts licensed for injection through an off-label route. No liquid SLIT formulation currently has FDA approval in the United States. AAAAI: immunotherapy methods

There is research supporting particular liquid SLIT preparations, but it does not establish that every mixture marketed as allergy drops works equally well. AAAAI notes uncertainty about U.S. extract-drop mixtures and the need to establish effective doses for individual formulations. An approved grass-tablet trial cannot validate a different custom liquid mixture. AAAAI: tablet and liquid SLIT evidence

Use in another country also does not establish U.S. approval or equivalence to the product you are being offered. Before buying drops, ask:

• What exact allergens and maintenance doses will I receive?
• What evidence supports this formulation for my condition?
• Who supervises the first dose and adjusts treatment?
• What are the epinephrine, missed-dose, mouth-injury, and emergency instructions?
• What is the full annual cost, including consultations and refills?

Safety and Side Effects: What Changes the Decision?

Local reactions and serious reactions are different

SCIT can cause redness, itching, and swelling at the injection site. Whole-body reactions are less common but can include anaphylaxis. SLIT more often causes mouth itching, throat irritation, or local swelling early in treatment. Its overall systemic-reaction risk is lower than SCIT's, but anaphylaxis remains possible. ACAAI: allergy shots · AAAAI: SLIT safety

Do not assume that increasing throat swelling is a harmless adjustment. Breathing difficulty, trouble swallowing, faintness, or rapidly progressing symptoms require immediate action. Follow your emergency plan, use prescribed epinephrine when indicated, and seek emergency medical care. Stop further dosing until your clinician advises you. FDA: Ragwitek Medication Guide

Asthma control comes first

Uncontrolled asthma increases immunotherapy risk. Your clinician should assess asthma before starting treatment and reassess symptoms during treatment. FDA-approved SLIT tablets must not be used in people with severe, unstable, or uncontrolled asthma. Tell the office about wheezing, an asthma flare, or worsening breathing before an injection or the next SLIT dose. FDA: Ragwitek prescribing information

These tablets are approved for the specified nasal/eye allergies, not as replacements for asthma controller or rescue medicines.

Eosinophilic esophagitis and mouth problems matter for SLIT

A history of eosinophilic esophagitis (EoE) is a contraindication to the approved SLIT tablets. Persistent difficulty swallowing, food sticking, or significant persistent chest or upper digestive symptoms during treatment need medical assessment. Product labeling also calls for holding treatment during certain mouth wounds, ulcers, or oral surgery until healing occurs. Ask when it is safe to restart. FDA: Odactra precautions

Review your full health and medication history, including previous severe allergic reactions, beta-blockers, other significant medical conditions, and pregnancy plans. These can affect suitability or emergency treatment. Do not stop prescribed medicines to make yourself eligible. AAO-HNSF: risk assessment before immunotherapy

Effectiveness, Multiple Allergies, and Long-Term Relief

Is SCIT more effective than SLIT?

Both established SCIT regimens and approved SLIT tablets can reduce relevant allergy symptoms and medication use. There is no defensible single percentage—or universal winner—for every allergen, product, and patient. Some comparisons favor SCIT, while other evidence finds similar symptom control. Direct comparisons are limited, and studies differ in doses and populations. 2024 Clinical Practice Guideline: Immunotherapy for Inhalant Allergy

The useful question is: Which adequately dosed treatment targets the allergens actually causing my symptoms, and can I complete its course? Claims that all drops equal shots, or that shots always outperform every tablet, go beyond what a product-specific discussion can support.

Multiple positive tests do not automatically rule out tablets

Being sensitized to several allergens does not mean each one causes equally important symptoms. A grass tablet may still be reasonable for someone whose main problem is grass season, even if other tests are positive. It will not reliably treat unrelated cat or tree allergy symptoms.

When several unrelated triggers each cause substantial problems, SCIT may offer a broader treatment plan. Guidelines also allow treating selected patients with a limited number of important allergens. Selection should follow the clinical history, not the size of a test panel. 2024 inhalant immunotherapy guideline

How long does treatment take, and will relief last?

Expect a long-term plan rather than a rapid cure. Improvement may emerge during the first year, but timing varies. Guidelines recommend at least three years for patients benefiting from inhalant immunotherapy, with further duration individualized. For shots, maintenance treatment commonly lasts 3–5 years. Some patients remain better after stopping; others relapse. 2024 inhalant immunotherapy guideline · AAAAI: duration and relapse

Do not translate that into “every tablet must be taken continuously for five years.” Seasonal and year-round regimens differ. Grastek's label, for example, describes three consecutive years of daily treatment to provide sustained effectiveness for one grass season after stopping. That finding should not be extended automatically to every SLIT product or drop mixture. FDA: Grastek prescribing information

Does immunotherapy prevent asthma?

There is evidence of possible preventive benefits in selected patients, but prevention is not guaranteed. In the five-year pediatric GAP trial, a grass SLIT tablet reduced asthma symptoms or asthma-medication use but did not meet its primary endpoint of delaying asthma onset under the study's definition. That is a reason to avoid promising that either route will prevent asthma. GAP randomized trial

Convenience, Costs, and Insurance: Compare the Full Course

Match the routine to your life

For shots, count travel, appointment time, observation, and the more frequent buildup visits. Ask whether another appropriately equipped office can administer the prescribed injections if you move or travel.

For SLIT, consider daily adherence, refills, storage instructions, supervised treatment for children, and access to your clinician when something changes. Home treatment reduces routine injection visits; it does not eliminate follow-up or emergency planning. ACAAI: managing SLIT at home

Neither option fits well if its schedule is unrealistic. Before starting, discuss what you can consistently maintain over several years.

What will you actually pay?

Shots and approved tablets may be covered, but covered does not mean free. Network status, deductibles, copays, coinsurance, and authorization rules affect your share. Liquid drops are usually self-pay in the United States. AAAAI: understanding allergy-care insurance · ACAAI: drop coverage

Ask for first-year and later-year estimates, using the same time horizon. Comparing a monthly drop subscription with only a shot copay leaves out important costs. Likewise, multiplying a seasonal tablet's monthly price by 12 may misrepresent the prescribed course.

Keep the estimate practical: “What will I owe for evaluation, treatment, and follow-up this year, and what changes next year?” Ask your insurer about the clinic's proposed services and the pharmacy about the exact prescription. Recheck benefits when your plan changes. Our First Allergist Appointment Guide explains consultation and testing bills in more detail.

Which Option Fits Your Situation?

Use these scenarios to prepare for a shared decision; they do not establish eligibility by themselves.

Venom immunotherapy is a distinct, established treatment for selected patients at risk of serious insect-sting reactions. ACAAI: insect sting allergy treatment

Before agreeing to treatment, ask your allergist:

1. Which allergens explain my symptoms, and which results do not need treatment?
2. What benefits are realistic for this specific prescription?
3. Is it FDA-approved for this route, condition, and age?
4. What makes it suitable—or unsuitable—for my asthma and other health conditions?
5. What should I do after a reaction, missed doses, dental work, or a change in medicines?
6. How will we measure improvement, and when will we reassess if it is not helping?
7. What are my expected costs and time commitments in year one and later years?

Frequently Asked Questions

Are allergy drops as effective as allergy shots?

You cannot assume that a custom liquid drop mixture works as well as shots or an FDA-approved tablet. Effectiveness depends on the allergens, dose, formulation, and schedule. Ask for evidence supporting the exact drops being offered, especially a mixture of unrelated allergens.

What is the difference between allergy tablets and allergy drops?

Both are placed under the tongue, but the U.S. regulatory and evidence standards differ. Grastek, Oralair, Ragwitek, and Odactra are FDA-approved tablets for specific allergies. No liquid SLIT formulation is FDA-approved in the United States.

Can you take allergy shots and allergy tablets at the same time?

Do not combine them on your own. Concurrent allergen immunotherapy is not well studied, and tablet labeling warns that combining treatments may increase local or systemic reactions. An allergist must assess any proposed combination, including more than one tablet product. FDA: Odactra combination-treatment warning

What happens if I miss a few days of SLIT tablets?

Follow the Medication Guide for your product and do not double a dose. Grastek and Ragwitek instruct patients who miss more than one dose to contact their healthcare provider before restarting. Your clinician should decide how to resume after an interruption and whether supervision is needed. FDA: Grastek Medication Guide · FDA: Ragwitek Medication Guide

What if I miss an allergy shot appointment?

Contact the clinic before returning. The next dose may need adjustment based on the length of the gap, your treatment phase, and your reaction history. Do not assume you can resume the previous dose or make up missed injections yourself. AAAAI: dose adjustment after injection gaps

Which allergy tablets are approved for children?

Grastek, Oralair, Ragwitek, and Odactra currently have U.S. approval for ages 5 through 65 for their specified nasal and eye allergies. Children need adult supervision, an appropriate emergency plan, and assessment of other eligibility criteria. Being old enough does not by itself make a product suitable.

Are shots better if I have several allergies?

Shots can treat a broader set of clinically relevant allergens, but several positive tests do not automatically make them the best choice. A targeted tablet may help when one covered allergen drives most symptoms. Your allergist should identify which exposures actually need treatment.

Can allergy tablets treat cat, dog, or mountain cedar allergy?

There is currently no FDA-approved SLIT tablet for cat, dog, mold, or mountain cedar allergy. An allergist can discuss other appropriate options, including selected injection immunotherapy. Off-label drops should be evaluated on their own formulation-specific evidence.

Do allergy shots or tablets cure allergies permanently?

They can provide lasting improvement, but a permanent cure is not guaranteed. Some people continue to need symptom medicines or relapse after stopping treatment. Set measurable goals with your allergist and review the response before deciding how long to continue.

Can I keep taking antihistamines or nasal sprays during immunotherapy?

Often yes. Symptom medicines may still be needed while immunotherapy takes effect. Ask your clinician which medicines to continue and when any changes are appropriate. Immunotherapy does not replace prescribed asthma controller or rescue treatment. ASCIA: medicines during immunotherapy

Do I need epinephrine if I use an allergy tablet?

Yes. FDA tablet labeling requires prescribed rescue epinephrine and instructions for recognizing and treating serious reactions. Make sure you know how to use the prescribed product and what emergency care to seek. Home dosing does not remove anaphylaxis risk. FDA: Odactra Medication Guide

Can I start immunotherapy while pregnant?

Immunotherapy is generally not started during pregnancy. If you become pregnant while already receiving treatment, contact your allergist and obstetric clinician. Established maintenance treatment may sometimes continue after an individualized assessment, particularly with allergy shots. AAAAI: asthma, allergies, and pregnancy

Does insurance cover allergy shots, tablets, or drops?

Shots and approved tablets may be covered, but your plan determines eligibility, authorization, and cost sharing. Liquid drops are usually self-pay. Compare a complete first-year estimate and later-year costs rather than assuming the advertised monthly price or office copay is the total.

Are allergy shots the same as steroid shots?

No. SCIT repeatedly gives selected allergen extracts to change the allergic response over time. A corticosteroid injection is a different treatment and is not allergen immunotherapy. Ask which medication or extract is being proposed if the term allergy shot is unclear.

Do environmental allergy shots or tablets treat food allergy?

They should not be used as a food allergy treatment plan. Food allergy immunotherapy involves different products or specialist protocols. Do not deliberately eat a known food allergen because you have started treatment for pollen, pets, or dust mites.

Your Next Step: Choose a Treatment You Can Sustain

Bring your allergy results, symptom calendar, medication list, schedule constraints, and insurance information to an immunotherapy consultation. A useful recommendation should explain the relevant allergens, the evidence for the product, the safety plan, and the full treatment commitment.

Use our allergist directory to find a local specialist, then confirm board certification, services, and network participation with the practice. Prepare for the discussion with What Happens at Your First Allergist Appointment?.

How This Guide Was Researched

This guide was researched on October 26, 2026 using current FDA prescribing information and medication guides, AAAAI and ACAAI patient resources, the published 2024 inhalant immunotherapy guideline, and the GAP randomized trial. Product labeling takes priority over generalized dosing descriptions.